In Alzheimer’s disease models, IL-1β expression is upregulated following Aβ deposition and exacerbates neuroinflammation by amplifying glial reactivity and cytokine release, thereby accelerating disease progression (41). This evidence concerns the gene IL1B and early-onset autosomal dominant Alzheimer disease.